We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Viridian Therapeutics
VRDN
$2.67B
| $15.7M | 0.02% |
503,868
+301,047
| +148% | +$8.26M |
|
802
Synchrony
SYF
$25.6B
| $15.6M | 0.02% |
187,463
+175,885
| +1,519% | +$13.4M |
|
|
Q
803
Qnity Electronics Inc
Q
$28.9B
| $15.6M | 0.02% |
+191,514
| New | +$16.3M |
|
|
HTBK
804
DELISTED
Heritage Commerce
HTBK
| $15.6M | 0.02% |
+1,301,168
| New | +$14.1M |
|
805
United Microelectronic
UMC
$47.5B
| $15.6M | 0.02% |
1,980,820
+1,886,996
| +2,011% | +$14.3M |
|
806
CALL
JPMorgan Chase
JPM
$963B
| $15.6M | 0.02% |
48,300
+22,600
| +88% | +$7M |
|
807
Mueller Water Products
MWA
$4.11B
| $15.5M | 0.02% |
+652,694
| New | +$16.2M |
|
808
PUT
Thermo Fisher Scientific
TMO
$223B
| $15.5M | 0.02% |
26,800
+21,900
| +447% | +$12.4M |
|
|
TGNA
809
PUT
DELISTED
TEGNA Inc
TGNA
| $15.5M | 0.02% |
+800,000
| New | +$15.8M |
|
810
Vishay Intertechnology
VSH
$5.09B
| $15.4M | 0.02% |
1,066,031
+306,950
| +40% | +$4.65M |
|
811
Shutterstock
SSTK
$203M
| $15.4M | 0.02% |
804,655
+560,617
| +230% | +$12M |
|
812
Steven Madden
SHOO
$3.55B
| $15.3M | 0.02% |
+367,633
| New | +$14.2M |
|
813
PUT
BP
BP
$111B
| $15.3M | 0.02% |
439,600
+415,400
| +1,717% | +$14.6M |
|
814
Enphase Energy
ENPH
$5.56B
| $15.2M | 0.02% |
475,528
+131,491
| +38% | +$4.26M |
|
815
PUT
Verizon
VZ
$196B
| $15.2M | 0.02% |
374,000
-291,500
| -44% | -$11.8M |
|
816
CALL
Rapid7
RPD
$918M
| $15.2M | 0.02% |
1,000,000
+400,000
| +67% | +$6.58M |
|
817
CALL
Bloom Energy
BE
$62.8B
| $15.2M | 0.02% |
174,500
+74,500
| +75% | +$7.83M |
|
818
Structure Therapeutics
GPCR
$3.74B
| $15M | 0.02% |
216,199
-245,354
| -53% | -$10M |
|
|
ETOR
819
eToro Group
ETOR
$2.35B
| $15M | 0.02% |
427,575
+256,861
| +150% | +$9.92M |
|
820
PUT
Adobe
ADBE
$105B
| $15M | 0.02% |
42,800
-10,700
| -20% | -$3.64M |
|
821
CAMP4 Therapeutics
CAMP
$269M
| $14.9M | 0.02% |
+2,436,900
| New | +$10.4M |
|
822
Bentley Systems
BSY
$10.7B
| $14.8M | 0.02% |
388,481
-18,118
| -4% | -$826K |
|
823
State Street Technology Select Sector SPDR ETF
XLK
$122B
| $14.8M | 0.02% |
+102,899
| New | +$14.9M |
|
824
PUT
Xcel Energy
XEL
$48.4B
| $14.8M | 0.02% |
+200,000
| New | +$15.8M |
|
825
Camping World
CWH
$654M
| $14.7M | 0.02% |
1,515,853
-989,924
| -40% | -$12.3M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.